Monthly Archives: August 2012

US Funding for Global AIDS and TB for the Next Fiscal Year?

By on .

With Congress adjourned until after Labor Day and not a single funding bill for the federal fiscal year beginning October signed into law before the recess even began, the virtual standstill of legislative action could have a mixed impact on global health funding. It appears that House and Senate leaders have reached a tentative agreement […]

CDC issues interim guidelines on preexposure antiretroviral use for heterosexual adults

By on .

The Centers for Disease Control and Prevention has released guidelines for clinicians prescribing antiretroviral medicine to prevent acquisition of HIV in heterosexual men and women, saying daily doses of Truvada can be safe and effective in reducing risk of infection. The guidelines, released in the agency’s August 10 Morbidity and Mortality Weekly Report, emphasize that […]

With sex workers and drug users banned from US travel, AIDS 2012 features sessions about them, without them

By on .

Some of the best news for some of those hit hardest by the epidemic came early in AIDS 2012 with Secretary Clinton’s welcoming remarks, when, citing progress in both science and implementation, while emphasizing the impact of the epidemic on sex workers and people who use injecting drugs, she told the audience ” . . […]

Forty Percent Price Cut for Rapid TB Test Announced

By on .

Yesterday, the Office of the Global AIDS Coordinator (GAC), USAID, UNITAID and the Bill & Melinda Gates Foundation announced an agreement that will reduce the price of Xpert MTB/RIF cartridges from $16.86 to $9.98 with funds provided through this partnership. And the price will not increase until 2022. Cepheild’s GeneXpert is a molecular diagnostic system […]

Lessons learned, lessons yet to be learned, Lancet’s MSM series, tuberculosis as kindling — HIV as the match, and more . . .

By on .

JAIDS all-PEPFAR supplement is free online and gives a past, present, future look at the President’s Emergency Plan For AIDS Relief as a historic effort that can still look forward to its greatest accomplishments. While the emphasis is on the program’s successes and a pre-AIDS 2012 panel discussion was light on the “lessons learned” from […]

WHO documents summarize current guidelines, progress, next steps, and pitfalls

By on .

Remember when one of the objections to rolling out life-saving treatment to people living with HIV in developing countries was that lack of capacity to maintain treatment would lead to drug resistance on a massive scale? While that didn’t happen at the scary levels projected, the transmission of drug resistant strains of HIV continue to […]